AmeriFlex Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.3K Sell
171
-187
-52% -$10.2K ﹤0.01% 937
2026
Q1
$22.5K Buy
358
+7
+2% +$560 0.01% 586
2025
Q4
$33.5K Sell
351
-351
-50% -$34.4K 0.02% 503
2025
Q3
$68.5K Buy
702
+354
+102% +$36.7K 0.03% 406
2025
Q2
$36.4K Hold
348
0.02% 447
2025
Q1
$35.1K Hold
348
0.01% 557
2024
Q4
$35.6K Buy
+348
New +$30.6K 0.02% 510

Other funds holding BSX

AmeriFlex Group's BSX Position: Q2 2026 in Review

AmeriFlex Group reduced its Boston Scientific (BSX) stake by 52% in Q2 2026, selling an estimated $10.2K and leaving 171 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

AmeriFlex Group first reported a position in BSX in Q4 2024 and has held it in 7 quarters since. The position peaked at $68.5K in Q3 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • AmeriFlex Group held 171 shares of Boston Scientific worth $7.3K as of Q2 2026.
  • AmeriFlex Group sold 187 Boston Scientific shares in Q2 2026, an estimated $10.2K.
  • Boston Scientific made up ﹤0.01% of AmeriFlex Group's portfolio in Q2 2026, its #937 holding.
  • AmeriFlex Group first reported a position in Boston Scientific in Q4 2024 and has held it in 7 quarters since.
  • AmeriFlex Group's Boston Scientific position peaked at $68.5K in Q3 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.